COMMUNITY

Naloxone: Liability, regulatory concerns for pharmacistsThe rules vary from state to state. Pharmacists need to stay informed.
Remember When: Pharmacists overwhelmingly support Reagan re-election bidThe more things change, the more more they remain the same.
DEA to consider rescheduling marijuana — for the fourth timeWill the DEA finally reclassify marijuana to schedule 2?
Revive tired dry eyes; safely clear ears of wax buildupNew OTC products for eyes and ears.
How to find satisfaction and reward in your pharmacy careerThere are so many opportunities for pharmacists out there. Technology can help uncover them, and we can follow them to a fulfilling career.
Medicare drug costs should parallel those of MedicaidMedicare should have the same authority that Medicaid has to negotiate drug prices directly with manufacturers. If the government can do it for one program, it can do it for another.
Point-of-care testing opens door to new patient-care modelCLIA-waived tests may be the next big thing.
Quit stigmatizing naloxoneEpinephrine saves lives. So does naloxone. Why are they regarded differently?
Pharmacists should get training in naloxone use nowPharmacists are the most accessible healthcare resource. Once trained in naloxone use, we can train our patients in all aspects of opioid use. This will make a difference.
Solutions to the ongoing opioid epidemic take shape"Naloxone should be the fire extinguisher in the home of everyone who is at risk."

Poll